Alfacalcidol
Back to searchMolecule Structure
Scientific Name
Alfacalcidol
Description of the Drug
Alfacalcidol is a vitamin D analogue used for the management of hypocalcemia, secondary hyperparathyroidism, and osteodystrophy in patients with chronic renal failure, as well as some types of rickets and osteomalacia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01436
http://www.drugbank.ca/drugs/DB01436
Brand Name(s)
Alfa d, Etalpha, One-alpha
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Vitamin D receptor | SINGLE PROTEIN | AGONIST | CHEMBL1977 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3063 | |
| PharmGKB | PA164746469 | |
| Human Metabolome Database | HMDB0015504 | |
| DrugBank | DB01436 | |
| PubChem: Thomson Pharma | 14879155 | 14928232 |
| PubChem | 5282181 | |
| PDBe | M9B | |
| EPA CompTox Dashboard | DTXSID0022569 | |
| LipidMaps | LMST03020231 | |
| DrugCentral | 130 | |
| Brenda | 41958 | |
| Rhea | 31186 | |
| rxnorm | ALFACALCIDOL | 1-ALPHA-VITAMIN D |
| PubChem: Drugs of the Future | 123055313 | |
| ChEBI | 31186 | |
| ZINC | ZINC000012484965 |
